{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:46:52Z","timestamp":1761238012408},"reference-count":9,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2013,9,19]]},"DOI":"10.4161\/hv.25203","type":"journal-article","created":{"date-parts":[[2013,7,11]],"date-time":"2013-07-11T17:19:05Z","timestamp":1373563145000},"page":"1910-1913","source":"Crossref","is-referenced-by-count":12,"title":["Pre-exposure prophylaxis against rabies in children"],"prefix":"10.1080","volume":"9","author":[{"given":"Haradanahalli S","family":"Ravish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayanthi","family":"Srikanth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doddabele Hanumanthaiah","family":"Ashwath Narayana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachana","family":"Annadani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veena","family":"Vijayashankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malatesh","family":"Undi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,10,27]]},"reference":[{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2005.10.007"},{"key":"R4","unstructured":"World Health Organization. WHO expert consultation on rabies. TRS 931. WHO Geneva 2005."},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.02.027"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.2310\/7060.2001.24445"},{"key":"R7","first-page":"589","volume":"5","author":"Sudarshan MK","year":"2011","journal-title":"Asian Biomedicine"},{"key":"R8","unstructured":"World Health Organization. Human and dog rabies prevention and control, Report of the WHO\/Bill & Melinda Gates foundation consultation, Annecy, France, 2009."},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)10085-4"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.4161\/hv.4.5.5987"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2007.02.044"}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.4161\/hv.25203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T22:58:07Z","timestamp":1481669887000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/abs\/10.4161\/hv.25203"}},"subtitle":["Safety of purified chick embryo cell rabies vaccine (Vaxirab N) when administered by intradermal route"],"short-title":[],"issued":{"date-parts":[[2013,9,19]]},"references-count":9,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,10,27]]},"published-print":{"date-parts":[[2013,9,19]]}},"alternative-id":["10.4161\/hv.25203"],"URL":"https:\/\/doi.org\/10.4161\/hv.25203","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,19]]}}}